Madero, M., Chertow, G. M. and Mark, P. B. (2024) SGLT2 inhibitor use in chronic kidney disease: supporting cardiovascular, kidney, and metabolic health. Kidney Medicine, (doi: 10.1016/j.xkme.2024.100851) (Accepted for Publication)
![[img]](https://cdn.statically.io/img/eprints.gla.ac.uk/style/images/fileicons/text.png) |
Text
325539.pdf - Accepted Version Restricted to Repository staff only 510kB |
| Item Type: | Articles |
|---|---|
| Status: | Accepted for Publication |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Mark, Professor Patrick |
| Authors: | Madero, M., Chertow, G. M., and Mark, P. B. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
| Journal Name: | Kidney Medicine |
| Publisher: | Elsevier |
| ISSN: | 2590-0595 |
| ISSN (Online): | 2590-0595 |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details